MedCap AB (publ) (STO:MCAP)

Market Cap	7.28B +21.6%
Revenue (ttm)	2.11B +16.6%
Net Income	219.80M +6.0%
EPS	14.67 +4.8%
Shares Out	15.02M
PE Ratio	33.07
Forward PE	26.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,945
Average Volume	20,135
Open	483.50
Previous Close	489.50
Day's Range	475.00 - 492.50
52-Week Range	329.00 - 677.00
Beta	0.52
RSI	47.58
Earnings Date	Feb 6, 2026

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Nordic region and Northern Europe. It typically invests between SEK25 millio...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 627
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MCAP

Financial Performance

In 2025, MedCap AB's revenue was 2.11 billion, an increase of 16.64% compared to the previous year's 1.81 billion. Earnings were 219.80 million, an increase of 5.98%.